Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DJI136 in Extensive-stage Small Cell Lung Cancer
NCT07564401Phase 2Recruiting
- Sponsor
- Novartis
- Start
- Jun 2026
- Primary completion
- Mar 2031
- Modality
- CAR-T Cells
- Countries
- 4
01
Overview
A Phase 2 trial of DJI136 in small cell lung cancer (SCLC), sponsored by Novartis. Started Jun 2026; status: recruiting.
02
Drugs
DJI136
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT07564401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07564401.